Legends for supplementary figures Fig s1. A: Western blot showing the suppression of SRp20 expression by Dox induction of SRp20 siRNAs in SKOV3 sublines.

Slides:

Advertisements

Similar presentations

Actin PEA Hey KOC-7c OVCA420 OVCA432 OVTOKO RMG-1 SKOV3.ip1 Supplementary Fig. S1. Expression level of endogenous PEA-15 in ovarian cancer cell.

Advertisements

(+++) Normal breast ATM (++) IDC ATM Lymph node metastasis negative positive P-value A B X200 C Vector ATM - WT.

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,

P-ERK β-tubulin VSShh + cyclopamine Supplementary Figure ESM 1a ERK MAP Kinase activity is not affected by Shh pathway activity. Western blot analysis.

Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.

Supplementary table 1 miR-506 expression and clinocopathological factors FactorsTotal number miR-506 low expressionmiR-506 high expression P-value (n =

SKOV3 ~44% SKBR3 ~6% SiHa ~89% CaSki i ~67% HeLa ~89% Supplementary Figure 1 Huisman et al Supplementary Figure 1. DNA methylation status of the EPB41L3.

Disease B A C SUPPLEMENTARY FIGURE 1 Molecular Function D.

Supplementary Figure 1 Supplementary Figure 1. Kaplan–Meier estimates of recurrence-free survival (RFS) according to the expression of every ten mRNA/lncRNA.

The role of regulatory B cells on hepatocellular carcinoma progression Conclusion Results Fig2. (A and B) In vivo, Bregs in SCID mice increased the size.

Supplemental Figure 1. Specificity of CCL2 and Fsp1 immunostaining of breast tumor tissues. Sections of invasive ductal carcinoma were incubated with primary.

Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer Ming-Chuan Wang, PhD, Ying-Hua Chang,

Volume 2, Issue 8, Pages (August 2015)

Table 2. Association between histology grade, lymph node status,

Date of download: 10/22/2017 Copyright © ASME. All rights reserved.

Neuroprotective Effect of Didymin on Hydrogen Peroxide-Induced Injury in the Neuronal Membrane System Cells Tissues Organs 2014;199: DOI: /

Figure S1. DCYTB expression is higher in ER+ than ER- patients

Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.

Supplementary Figure S2

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer C.E. Henry, C. Emmanuel, N.

Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo: Synergism with Chemotherapy Mir Alireza Hoda, MD, Amir Mohamed, BSc,

Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing.

Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis Ruo-Chia Tseng, PhD, Jia-Ming Chang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

Induction of apoptosis by CDIP expression.

Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT Zhen-Yu He, San-Gang Wu, Fang Peng,

Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin

Volume 136, Issue 2, Pages e1 (February 2009)

Volume 137, Issue 2, Pages e2 (August 2009)

c‐Abl acetylation on Lys 730 promotes myogenic differentiation.

Volume 138, Issue 4, Pages (April 2010)

RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells Anja Berger, Sandra-Annika Quast, Michael Plötz, Nicholas-Frederik Kuhn,

Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway Tatsuo Nakahara, M.D., Akira Iwase, M.D., Ph.D.,

Verena N. Lorenz, Michael P. Schön, Cornelia S. Seitz

Cell Physiol Biochem 2016;39: DOI: /

Sunny Guin, PhD, Yuanbin Ru, PhD, Murry W

Recombinant OPCML protein effect in vitro.

Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer Ming-Chuan Wang, PhD, Ying-Hua Chang,

Volume 19, Issue 6, Pages (June 2011)

EIF4E Is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion Shahram Khosravi, Kevin J. Tam, Gholamreza S.

Relative mRNA expression level (/J3T-1)

Supplementary Figure 2. AKT1 AKT1 AKT2 pAKT ERK pERK A1847 A2780 CaOV3

Volume 140, Issue 3, Pages (March 2011)

Volume 4, Issue 3, Pages (August 2013)

Expression of THBS2 in human PanIN tissue and PDAC tumor tissue

Disrupted dynamics of early stages of differentiation perturbs neural cell fate specification. Disrupted dynamics of early stages of differentiation perturbs.

Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis

Hdac3 deletion decreases AKT phosphorylation and tumor growth in Pten knockout prostate cancer Hdac3 deletion decreases AKT phosphorylation and tumor growth.

Volume 40, Issue 3, Pages e5 (February 2017)

Triple‐negative human breast cancers specifically express high levels of nuclear HMGA2, whose expression has clinical relevance and predicts recurrence‐free.

Volume 17, Issue 2, Pages (February 2009)

Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small- Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis.

TIPI mediates rapid degradation of proteins in yeast.

High CDK6 expression predicts poor prognosis in EOC patients

T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells.

Glutamine addiction and cancer invasiveness are positively correlated in ovarian cancer cells (OVCA) Gln deprivation effect on proliferation rate of a.

This month in Gastroenterology

CYP1A1 knockdown increases cell death.

The expression of SPINDLIN1 in cancer tissues.

Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma cells. Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma.

PD-1 expression in ovarian cancer.

Correlation of PTEN loss in melanoma cells with an immune resistance phenotype. Correlation of PTEN loss in melanoma cells with an immune resistance phenotype.

Fig. 5 C9orf72 knockdown disrupts autophagy induction.

Molecular definitions of lung adenocarcinoma subtypes.

AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.

Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3 S284 through MDM2. Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3.

Arati Sridharan, Chetan Patel, Jit Muthuswamy

GCS-100 selectively kills KRAS-addicted lung tumors.

Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.

Parthenolide inhibits tumor promotion and increases p21 expression in vivo. Parthenolide inhibits tumor promotion and increases p21 expression in vivo.

Presentation transcript:

Legends for supplementary figures Fig s1. A: Western blot showing the suppression of SRp20 expression by Dox induction of SRp20 siRNAs in SKOV3 sublines. B: Cell growth curve. Shown are the results of three independent experiments. Error bars represent standard error. C: Left panel, sample micrographs of Hoechst stained nuclei of SKOV3 subline cells. Arrow indicates the typical apoptotic cells. Right panel, Quantitation of apoptotic cells. Fig s2. A: Western blot showing the suppression of SRp20 expression by Dox induction of SRp20 siRNAs in IGROV1 sublines. B: Cell growth curve of IGROV1 sublines. C: Left panel, sample micrographs of Hoechst stained nuclei of IGROV1 subline cells. Arrow indicates the typical apoptotic cells. Right panel, Quantitation of apoptotic cells.

Dox SKOV3 β-actin SRp20 SRp20si1SRp20si2 - + LUCsi - + Fig s1 A B C SKOV3/LUCsi SKOV3/SRp20si1 SKOV3/SRp20si2 Without DoxWithDox % Knockdown 6791

SRp20si1SRp20si2LUCsi - + Dox - + β-actin SRp20 IGROV1 Fig s2 A B C Without DoxWith Dox IGROV1/LUCsi IGROV1/SRp20si1 IGROV1/SRp20si2 % Knockdown 4779

† Evaluable cases require at least two satisfactory cores with staining for either PTB or SRp20. Disease Status Satisfactory Cores per Case Evaluable Cases † Total Cases Histologic Subtype for Evaluable Cases 0123MucinousSerousClear CellEndometrioid Poorly Differentiated PTB staining Benign Borderline/LMP Invasive Total SRp20 staining Benign Borderline/LMP Invasive Total Table s1. Distribution of Evaluable and Total Cases by Disease Status, Number of Satisfactory Cores and Histologic Subtype in the Disease Status TMA Stained for PTB or SRp20.

Disease status PTB †SRp20 ‡ All Negative Mixed All Positive Total All Negative Mixed All Positive Total Benign7 (46.7)5 (33.3)3 (20.0)151 (14.3)3 (42.9) 7 Borderline/LMP8 (32.0)7 (28.0)10 (40.0)250 (0)9 (40.9)13 (59.1)22 Invasive2 (7.7)5 (19.2)19 (73.1)260 (0)2 (8.0)23 (92.0)25 Total Table s2. Differential expression of PTB or SRp20 in the mucinous ovarian tumors in the Disease Status TMA Percentage within each staining category is provided in parentheses. Statistical significance was evaluated using Fisher’s exact test for data in 2 x 2 tables [43]; and the Mehta and Patel version of Fisher’s exact test for data in R x C tables [44]. † p= for overall test; p= for benign vs. invasive; p>0.05 for benign vs. borderline/LMP; p=0.036 for borderline/LMP vs. invasive. ‡ p= for overall test; p=0.012 for benign vs. invasive; p>0.05 for benign vs. borderline/LMP; p=0.014 for borderline/LMP vs. invasive.

Table s3. Distribution of Evaluable and Total Cases by Tumor Stage, Number of Satisfactory Cores and Histologic Subtype in the Tumor Stage TMA Stained for PTB or SRp20 † Evaluable cases require at least two satisfactory cores with staining for either PTB or SRp20. Tumor Stage Satisfactory Cores per Case Evaluable Cases † Total Cases Histologic Subtype for Evaluable Cases 0123EndometrioidSerous Mixed Epithelial PTB staining Stage I Stage II Stage III Stage IV Total SRp20 staining Stage I Stage II Stage III Stage IV Total

Categorized stage PTB †SRp20 ‡ LowHighTotalLowHighTotal Early stage (I+II)50 (66.7%)25 (33.3%)7542 (60.0%)28 (40.0%)70 Advanced stage (III+IV)45 (47.9%)49 (52.1%)9432 (35.2%)59 (64.8%)91 Total Table s4. Intensity of PTB or SRp20 staining in the Ovarian Cancer Stage TMA Statistical significance was evaluated using Fisher’s Exact test [43]. Staining intensity was categorized as low (score<2.5) or high (score  2.5). † p=0.019 for comparison of early stage vs. advanced stage. ‡ p=0.002 for comparison of early stage vs. advanced stage.